StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 03/01/2013 -- StockRunway.com issues special report on Over Bought Stocks – NetSpend Holdings Inc (NASDAQ:NTSP), Safeway Inc. (NYSE:SWY), Campbell Soup Company (NYSE:CPB), Celldex Therapeutics, Inc. (NASDAQ:CLDX).
NetSpend Holdings Inc (NASDAQ:NTSP) was trading higher by +0.02 points or +0.14% to 15.87. So far, around 1.62 million shares have changed hands in this session. After opening at $15.90, the stock hit as high as $15.91. However, it traded between $6.41 and$15.98 over the last twelve months. Netspend Holdings, Inc., together with its subsidiaries, provides general purpose reloadable (GPR) prepaid debit and payroll cards, and alternative financial service solutions to underbanked and other consumers in the United States.
Will NTSP Continue To Move Higher? Find Out Here
Safeway Inc. (NYSE:SWY) was at $24.20, showing a +1.47% increase. Around 1.94 million shares have been traded, versus an-average trading volume of 7.10 million shares. The company is now valued at around $5.80 billion. Safeway Inc., together with its subsidiaries, operates as a food and drug retailer in North America. Its stores provide a range of food and general merchandise; and consist of various specialty departments, such as bakery, delicatessen, floral, seafood, and pharmacy, as well as Starbucks coffee shops, and adjacent fuel centers.
Why Should Investors Buy SWY After The Recent Gain? Just Go Here and Find Out
Campbell Soup Company (NYSE:CPB) moved +1.90 per cent higher at $41.94 and is trading between $41.07 and $42.04 after opening the day at $41.18. Its performance over the last five days remained +4.56%, which stands at +14.05% for a month. Going back further than one month, 1-year performance after recent close was +26.54%. Campbell Soup Company, together with its subsidiaries, engages in the manufacture and marketing of branded convenience food products worldwide. The company offers condensed and ready-to-serve soups, broth and stocks, pasta and Mexican sauces, canned poultry, juices and beverages, and tomato juices, as well as canned gravies.
What was the Moving Force behind CPB On Bullish Run? Read This Research Report on CPB
Celldex Therapeutics, Inc. (NASDAQ:CLDX)’s shares rose today, gaining +10.61 per cent to $10.53. The stock is up around +56.63% in 2013 and +177.31% for the last 12 months. Around 1.73 million shares changed hands so far in this session compared to an-average trading volume of 1.55 million shares. Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. The company markets Rotarix to treat rotavirus infection.
For How Long CLDX will Fight for Profitability? Read This Trend Analysis report
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)